AN2 Therapeutics | Investor Presentation Deck | 25 slides · page 10 of 25
The slide uses a two-part table structure to contrast standard care with refractory care, emphasizing toxicity and lack of FDA approval for many agents.
Pitch deck · problem_statement · frame_problem · balanced density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 paragraph 1/1 table 2/2 title 1/1
Components 5
primary paragraph data data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.